Epo Adverse events reports from 11/01/97 to 08/27/12
The following are the statistics of AE reports based upon two variables:Epo primary suspect versus Total number of events reported.
Hospitalization Initial or Prolonged 761 versus 3998
Others 623 verus 3028
Death 244 versus 1573
Life threatening 27 versus 608
Require intervention to prevent permanent impairment damage 21 versus 465
Disability 15 versus 306
So, Godwinpeak please tell us how safe is Epo?
Pearl studies dealt with cardivascular events not sensitivity which is what this recall is all about.
Pearl study was for non-dialysis patients.
Pearl study along with the other THREE studies done at that time ALL MET THEIR PRIMARY END POINTS.
Pearl study is insignificant and won't even be considered. Old News.